Pedersen, Martin H <br/><br/>
CYPOR is a novel and independent prognostic biomarker of recurrence-free survival in triple-negative breast cancer patients.  [electronic resource] 

 -  International journal of cancer  02 2019 
 - 631-640 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1097-0215 
<br/><br/><label>Standard No.: </label>10.1002/ijc.31798  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Biomarkers, Tumor--biosynthesis<br/>Cohort Studies<br/>Disease-Free Survival<br/>Female<br/>Gene Expression<br/>Humans<br/>Immunohistochemistry<br/>Lymph Nodes--pathology<br/>Lymphatic Metastasis<br/>Middle Aged<br/>NADPH-Ferrihemoprotein Reductase--biosynthesis<br/>Neoplasm Recurrence, Local--enzymology<br/>Triple Negative Breast Neoplasms--enzymology